The Pharmacy and Poisons Board (PPB) has issued a recall for Efinox nasal drops following a labelling and packaging error affecting two specific batches: Efinox 1% w/v (Batch No. 82979) and Efinox 0.5% w/v (Batch No. 82978).

In a statement, the PPB explained that investigations by Laboratory and Allied Limited Kenya uncovered a mix-up, where the correct products were identified, but incorrect strength labels were applied.

Owing to this, the Board instructed all pharmaceutical outlets and healthcare facilities to stop further distribution, sale and issuance or use of the affected batches. 

Further, the public was advised to return the products to the nearest healthcare facility or respective suppliers. 

"The Board encourages the public to report any suspected cases of sub-standard medicines or adverse drug reactions to the nearest healthcare facility or the Pharmacy and Poisons Board," the statement read in part. 

Efinox is commonly used as a nasal drop for temporary relief of nasal congestion caused by conditions such as the common cold and fever.

Established as a regulatory authority under the Pharmacy and Poisons Act, the Board is mandated to ensure the quality and safety of medical products across all healthcare facilities.